[CHEMOTHERAPY OF MALIGNANT NEOPLASMS].
D000477:Alkylating Agents; D000818:Animals; D000963:Antimetabolites; D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D002822:Choriocarcinoma; D003609:Dactinomycin; D005260:Female; D005770:Gastrointestinal Neoplasms; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia; D008175:Lung Neoplasms; D008223:Lymphoma; D016403:Lymphoma, Large B-Cell, Diffuse; D008228:Lymphoma, Non-Hodgkin; D009101:Multiple Myeloma; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000628:therapy*; D010051:Ovarian Neoplasms; D011087:Polycythemia Vera; D011247:Pregnancy; D012509:Sarcoma; D009396:Wilms Tumor
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D003609:Dactinomycin
ACTINOMYCIN; ALKYLATING AGENTS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHORIOCARCINOMA; GASTROINTESTINAL NEOPLASMS; HODGKIN'S DISEASE; LEUKEMIA; LUNG NEOPLASMS; LYMPHOSARCOMA; MULTIPLE MYELOMA; NEOPLASM METASTASIS; NEOPLASM THERAPY; NEPHROBLASTOMA; OVARIAN NEOPLASMS; POLYCYTHEMIA VERA; SARCOMA, RETICULUM CELL
CHEMOTHERAPIE BIJ MALIGNE NIEUWVORMINGEN.